# A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer

> **NCT02833233** · NA · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 5 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Cryoablation
- **DRUG:** Ipilimumab
- **DRUG:** Nivolumab

## Key facts

- **NCT ID:** NCT02833233
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2024-06-07
- **Final completion:** 2024-06-07
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2024-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02833233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02833233, "A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02833233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*